Community/Retail

In its statement, NACDS emphasized chain pharmacy's initiatives to comply with DEA's "cradle-to-grave" regulation structure.

Research conducted by CVS Health supported its move to discontinue sales of tobacco products.

The new Elecsys anti-Müllerian Hormone fertility test increases the accuracy of ovarian reserve assessment compared to conventional methods.

In a Phase 3 study, odanacatib significantly reduced the risk of osteoporotic fractures, but it also might have contributed to major cardiovascular events.

Fred Eckel, RPh, MS, details how provider status would impact pharmacists' daily practice.

The 23 Insight Sessions featured at the 2014 NACDS Total Store Expo addressed a wide range of challenges affecting today's pharmacy landscape.

Fred Eckel, RPh, MS, explains why the lack of readily available resources amid expanding responsibilities is the biggest challenge for pharmacists in the current industry landscape.

Alpha-2-macroglobulin may soon revolutionize the treatment of osteoarthritis.

Thousands of US military personnel will deploy to West Africa.

Using a less market-oriented payment scheme could reduce high hospital administrative costs.

The FDA has granted approval for the use of hemophilia B treatment Rixubis in pediatric patients.

The FDA today approved AstraZeneca's naloxegol (Movantik) treatment for opioid-induced constipation in adults with chronic noncancer pain.

Through the Pharmacist Connect program, pharmacists from chain member companies provided 2014 NACDS Total Store Expo attendees with immunizations and other pharmacy services.

New coalition will focus on research and education to combat the abuse and misuse of stimulant medications on college campuses.

The respiratory virus that hospitalized hundreds of children in the Midwest and the South has now reached the Northeast.

Researchers found that inhibiting development of T helper 2 cells may be advantageous in the control of allergic responses.

Only 30% of the most commonly used mHealth apps have privacy policies.

Results of a phase 3 trial demonstrate the effectiveness of simeprevir in combination with ribavirin and peginterferon as a treatment for patients coinfected with HIV and HCV.

The FDA has granted priority review to a supplemental New Drug Application that would expand the use of lisdexamfetamine dimesylate (Vyvanse) to treat adult patients with binge eating disorder.

Approximately 6.5 million Americans are prescribed digoxin, a cardiac glycoside with a long, fascinating history.

Sam Stolpe, PharmD, describes several quality measures that revolve around safe and appropriate medication use.

Adding to the roving reporter system of the inaugural NACDS-TV, the video resource for the 2014 NACDS Total Store Expo incorporated a studio at the entrance to the exhibit floor.

Tom Hubbard believes the quality measures that generate star ratings for Medicare Prescription Drug Plans are the most relevant metrics for pharmacists.